BIO-key, Provider of Identity & Access Management Cybersecurity Solutions, Hosts Q1 Investor Call Monday, May 16th at 10am ET
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) will discuss its first quarter results in a conference call on May 16, 2022, at 10 a.m. ET. The earnings report will be available pre-market that morning. Key executives, including Chairman & CEO Mike DePasquale and CFO Cecilia Welch, will present during the call. Investors can access the live webcast or replay for three months, ensuring transparency in performance evaluation. The company specializes in Identity-Bound Biometrics and has extensive experience in identity and access management solutions.
Positive
- Scheduled conference call indicates commitment to transparency and investor communication.
- Focus on Identity-Bound Biometrics may signal growth potential in the IAM market.
Negative
- No financial metrics or results provided ahead of the call may raise investor uncertainty.
News Market Reaction – BKYI
In the trading session that priced this news, BKYI declined 6.51%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) and large-scale identity solutions, will review its first quarter results in a conference call Monday, May 16, 2022 at 10 a.m. ET. Results will be released pre-market that morning. Mike DePasquale, Chairman & CEO; Cecilia Welch, CFO; and Kimberly Johnson, VP of Product will participate on the call.
| Conference Call Details | |
| Date / Time: | Monday, May 16th at 10 a.m. ET |
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 International |
| Live Webcast / Replay: | Investor Webcast & Replay – Available for 3 months. |
| Audio Replay: | 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 3884798 |
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including PortalGuard that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| Twitter – Corporate: | @BIOkeyIntl |
| Twitter – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
| Media Contact | Investor Contact |
| Erin Knapp | William Jones, David Collins |
| Matter Communications | Catalyst IR |
| BIO-key@matternow.com | BKYI@catalyst-ir.com |
| 914-260-3158 | 212-924-9800 |
